WallStreetZenWallStreetZen

NASDAQ: CMPX
Compass Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

CMPX earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$42.5M
Current Profit Margin
0%

CMPX Return on Equity

Current Company
-26.1%
Current Industry
-63.5%
Current Market
188%
CMPX's Return on Equity (-26.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CMPX announces earnings.

CMPX Return on Assets

Current Company
-24.5%
Current Industry
2.9%
CMPX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CMPX Return on Capital Employed

Current Company
-28.51%
Current Industry
19.5%
CMPX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CMPX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CMPX$0.00-$40.60M-$42.49MN/AN/A
ACRV$0.00-$59.07M-$60.39MN/AN/A
ELEV$0.00-$45.64M-$45.70MN/AN/A
ATOS$0.00-$30.07M-$30.09MN/AN/A
DSGN$0.00-$66.29M-$66.86M-100.00%N/A
View Top Biotech Stocks

CMPX earnings dates

Next earnings date
May 6, 2024

Compass Therapeutics Earnings & Revenue FAQ

What were CMPX's earnings last quarter?

On Invalid Date, Compass Therapeutics (NASDAQ: CMPX) reported Q4 2023 earnings per share (EPS) of -$0.10, up 0% year over year. Total Compass Therapeutics earnings for the quarter were -$13.42 million. In the same quarter last year, Compass Therapeutics's earnings per share (EPS) was -$0.10.

If you're new to stock investing, here's how to buy Compass Therapeutics stock.

What was CMPX's earnings growth in the past year?

As of Q2 2024, Compass Therapeutics's earnings has grown year over year. Compass Therapeutics's earnings in the past year totalled -$42.49 million.

What is CMPX's earnings date?

Compass Therapeutics's earnings date is Invalid Date. Add CMPX to your watchlist to be reminded of CMPX's next earnings announcement.

What was CMPX's revenue last quarter?

On Invalid Date, Compass Therapeutics (NASDAQ: CMPX) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Compass Therapeutics's revenue was $0.00.

What was CMPX's revenue growth in the past year?

As of Q2 2024, Compass Therapeutics's revenue has grown null year over year. Compass Therapeutics's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.